iRhythm Technologies (IRTC) PT Raised to $160 as Canaccord Genuity Models Increased Medicare Reimbursement Rates
Tweet Send to a Friend
Canaccord Genuity analyst William Plovanic raised the price target on iRhythm Technologies (NASDAQ: IRTC) to $160.00 (from $125.00) to reflect ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
